# FDA Inspection 980726 - Biomat USA, Inc. - June 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3375abfd-cbab-48ee-a027-48ecb97b833e
Source feed: FDA_Inspections

> FDA Inspection 980726 for Biomat USA, Inc. on June 21, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 980726
- Company Name: Biomat USA, Inc.
- Inspection Date: 2016-06-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254129 - 2024-11-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/60317ec8-26dc-4a7e-b911-e3a0d9941898)
- [FDA Inspection 1254129 - 2024-11-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cffa8c98-6cb9-40d1-a99f-68457245a199)
- [FDA Inspection 1099928 - 2019-08-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2112f251-c2f4-4a51-9de6-e0668a44130f)
- [FDA Inspection 1034540 - 2017-10-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/91c40358-0f8f-4168-950b-1e122fa0db17)
- [FDA Inspection 857568 - 2013-11-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/069b20a2-570a-4dca-88c6-a74193d7512e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/21a3c056-72f5-4064-ba8d-41c59b7fef6a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d